FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1502875771> ?p ?o ?g. }

• W1502875771 endingPage "452" @default.
• W1502875771 startingPage "444" @default.
• W1502875771 abstract "Schmid, V.B., Seewald, W., Lees, P., King, J.N. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study. J. vet. Pharmacol. Therap . 33 , 444–452. Robenacoxib is a novel nonsteroidal anti‐inflammatory drug (NSAID) developed for use in companion animals. Whole blood assays were used to characterize in the cat the pharmacodynamics of robenacoxib for inhibition of the cyclooxygenase (COX) isoforms, COX‐1 and COX‐2, in comparison with other NSAIDs. Based on in vitro IC 50 COX‐1:IC 50 COX‐2 ratios, robenacoxib was COX‐2 selective (ratio = 32.2), diclofenac (ratio = 3.9) and meloxicam (ratio = 2.7) were only weakly COX‐2 preferential, and ketoprofen (ratio = 0.049) was COX‐1 selective. In an in vivo pharmacokinetic ex vivo pharmacodynamic study, after both p.o. (1–2 mg/kg) and subcutaneous (2 mg/kg) dosing, robenacoxib achieved peak blood concentrations rapidly ( T max = 1 h for both administration routes) and was cleared from blood relatively rapidly (mean residence time was 1.70 h after p.o. and 1.79 h after subcutaneous dosing). In ex vivo COX isoform inhibition assays, orally (1–2 mg/kg) or subcutaneously (2 mg/kg) administered robenacoxib significantly inhibited COX‐2, with a relatively short duration of action in the central compartment, and had no effect on COX‐1. Therefore robenacoxib was COX‐2 selective and spared COX‐1 in vivo . In contrast, meloxicam (0.3 mg/kg via subcutaneous injection) inhibited both COX‐1 and COX‐2 isoforms significantly for at least 24 h, indicating nonselectivity in vivo ." @default.
• W1502875771 created "2016-06-24" @default.
• W1502875771 creator A5007405150 @default.
• W1502875771 creator A5062321765 @default.
• W1502875771 creator A5070000403 @default.
• W1502875771 creator A5078296331 @default.
• W1502875771 date "2010-09-14" @default.
• W1502875771 modified "2023-10-16" @default.
• W1502875771 title "In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study" @default.
• W1502875771 cites W1972160955 @default.
• W1502875771 cites W1980365591 @default.
• W1502875771 cites W1990079369 @default.
• W1502875771 cites W1997364548 @default.
• W1502875771 cites W1998970599 @default.
• W1502875771 cites W1999380555 @default.
• W1502875771 cites W2009228494 @default.
• W1502875771 cites W2014466088 @default.
• W1502875771 cites W2016652018 @default.
• W1502875771 cites W2017749860 @default.
• W1502875771 cites W2018728665 @default.
• W1502875771 cites W2020092959 @default.
• W1502875771 cites W2025838546 @default.
• W1502875771 cites W2026374776 @default.
• W1502875771 cites W2027133715 @default.
• W1502875771 cites W2029066783 @default.
• W1502875771 cites W2038410983 @default.
• W1502875771 cites W2052001792 @default.
• W1502875771 cites W2058336082 @default.
• W1502875771 cites W2104379105 @default.
• W1502875771 cites W2137322951 @default.
• W1502875771 cites W2158735781 @default.
• W1502875771 cites W4247823079 @default.
• W1502875771 doi "https://doi.org/10.1111/j.1365-2885.2010.01166.x" @default.
• W1502875771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20840388" @default.
• W1502875771 hasPublicationYear "2010" @default.
• W1502875771 type Work @default.
• W1502875771 sameAs 1502875771 @default.
• W1502875771 citedByCount "31" @default.
• W1502875771 countsByYear W15028757712012 @default.
• W1502875771 countsByYear W15028757712013 @default.
• W1502875771 countsByYear W15028757712014 @default.
• W1502875771 countsByYear W15028757712015 @default.
• W1502875771 countsByYear W15028757712016 @default.
• W1502875771 countsByYear W15028757712018 @default.
• W1502875771 countsByYear W15028757712020 @default.
• W1502875771 countsByYear W15028757712022 @default.
• W1502875771 countsByYear W15028757712023 @default.
• W1502875771 crossrefType "journal-article" @default.
• W1502875771 hasAuthorship W1502875771A5007405150 @default.
• W1502875771 hasAuthorship W1502875771A5062321765 @default.
• W1502875771 hasAuthorship W1502875771A5070000403 @default.
• W1502875771 hasAuthorship W1502875771A5078296331 @default.
• W1502875771 hasBestOaLocation W15028757712 @default.
• W1502875771 hasConcept C111113717 @default.
• W1502875771 hasConcept C112705442 @default.
• W1502875771 hasConcept C150903083 @default.
• W1502875771 hasConcept C181199279 @default.
• W1502875771 hasConcept C185592680 @default.
• W1502875771 hasConcept C202751555 @default.
• W1502875771 hasConcept C207001950 @default.
• W1502875771 hasConcept C26291073 @default.
• W1502875771 hasConcept C2779689624 @default.
• W1502875771 hasConcept C2779751750 @default.
• W1502875771 hasConcept C55493867 @default.
• W1502875771 hasConcept C71924100 @default.
• W1502875771 hasConcept C86803240 @default.
• W1502875771 hasConcept C98274493 @default.
• W1502875771 hasConceptScore W1502875771C111113717 @default.
• W1502875771 hasConceptScore W1502875771C112705442 @default.
• W1502875771 hasConceptScore W1502875771C150903083 @default.
• W1502875771 hasConceptScore W1502875771C181199279 @default.
• W1502875771 hasConceptScore W1502875771C185592680 @default.
• W1502875771 hasConceptScore W1502875771C202751555 @default.
• W1502875771 hasConceptScore W1502875771C207001950 @default.
• W1502875771 hasConceptScore W1502875771C26291073 @default.
• W1502875771 hasConceptScore W1502875771C2779689624 @default.
• W1502875771 hasConceptScore W1502875771C2779751750 @default.
• W1502875771 hasConceptScore W1502875771C55493867 @default.
• W1502875771 hasConceptScore W1502875771C71924100 @default.
• W1502875771 hasConceptScore W1502875771C86803240 @default.
• W1502875771 hasConceptScore W1502875771C98274493 @default.
• W1502875771 hasIssue "5" @default.
• W1502875771 hasLocation W15028757711 @default.
• W1502875771 hasLocation W15028757712 @default.
• W1502875771 hasLocation W15028757713 @default.
• W1502875771 hasOpenAccess W1502875771 @default.
• W1502875771 hasPrimaryLocation W15028757711 @default.
• W1502875771 hasRelatedWork W2048465297 @default.
• W1502875771 hasRelatedWork W2074107478 @default.
• W1502875771 hasRelatedWork W2181305952 @default.
• W1502875771 hasRelatedWork W2254638634 @default.
• W1502875771 hasRelatedWork W2357299095 @default.
• W1502875771 hasRelatedWork W2369345461 @default.
• W1502875771 hasRelatedWork W2374782549 @default.
• W1502875771 hasRelatedWork W2402705660 @default.
• W1502875771 hasRelatedWork W2417307902 @default.
• W1502875771 hasRelatedWork W3097984823 @default.
• W1502875771 hasVolume "33" @default.

• next